| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 6e-05 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |